CDK9-IN-1

Overview

CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection , with an IC 50 of 39 nM for CDK9/CycT1, extracted from reference, compound 87.

Application

Products | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Ovarian Cancer | Products > Disease Areas > Urogenital Cancer | Products > Disease Areas > Viral Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Urogenital Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > CDK | Products > Signaling Pathways > HIV

Product Information

• Catalog No.: HY-13231
• CAS No.: 1415559-43-1
• Molecular Formula: C26H21N5O4S
• Molecular Weight: 499.54
• Purity: 98.52%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.00 mM); Clear solution
• Availability: In-stock

Source

Original product source